305 related articles for article (PubMed ID: 24992976)
1. [Importance of the tumor stem cell hypothesis for understanding ovarian cancer].
Vochem R; Einenkel J; Horn LC; Ruschpler P
Pathologe; 2014 Jul; 35(4):361-70. PubMed ID: 24992976
[TBL] [Abstract][Full Text] [Related]
2. Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance.
Ahmed N; Abubaker K; Findlay J; Quinn M
J Cell Biochem; 2013 Jan; 114(1):21-34. PubMed ID: 22887554
[TBL] [Abstract][Full Text] [Related]
3. CD10
Ffrench B; Gasch C; Hokamp K; Spillane C; Blackshields G; Mahgoub TM; Bates M; Kehoe L; Mooney A; Doyle R; Doyle B; O'Donnell D; Gleeson N; Hennessy BT; Stordal B; O'Riain C; Lambkin H; O'Toole S; O'Leary JJ; Gallagher MF
Cell Death Dis; 2017 Oct; 8(10):e3128. PubMed ID: 29048400
[TBL] [Abstract][Full Text] [Related]
4. [The role of cancer stem cells in progressive growth and resistance of ovarian cancer: true or fiction?].
Bar JK; Grelewski P; Lis-Nawara A; Drobnikowska K
Postepy Hig Med Dosw (Online); 2015 Sep; 69():1077-86. PubMed ID: 26400893
[TBL] [Abstract][Full Text] [Related]
5. Enrichment for chemoresistant ovarian cancer stem cells from human cell lines.
Cole JM; Joseph S; Sudhahar CG; Cowden Dahl KD
J Vis Exp; 2014 Sep; (91):51891. PubMed ID: 25285606
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer stem cells: opportunities and challenges.
Chhabra R
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1889-97. PubMed ID: 25563493
[TBL] [Abstract][Full Text] [Related]
7. Alternative splice variants of DCLK1 mark cancer stem cells, promote self-renewal and drug-resistance, and can be targeted to inhibit tumorigenesis in kidney cancer.
Ge Y; Weygant N; Qu D; May R; Berry WL; Yao J; Chandrakesan P; Zheng W; Zhao L; Zhao KL; Drake M; Vega KJ; Bronze MS; Tomasek JJ; An G; Houchen CW
Int J Cancer; 2018 Sep; 143(5):1162-1175. PubMed ID: 29577277
[TBL] [Abstract][Full Text] [Related]
8. Autotaxin Regulates Maintenance of Ovarian Cancer Stem Cells through Lysophosphatidic Acid-Mediated Autocrine Mechanism.
Seo EJ; Kwon YW; Jang IH; Kim DK; Lee SI; Choi EJ; Kim KH; Suh DS; Lee JH; Choi KU; Lee JW; Mok HJ; Kim KP; Matsumoto H; Aoki J; Kim JH
Stem Cells; 2016 Mar; 34(3):551-64. PubMed ID: 26800320
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells: the 'Achilles heel' of chemo-resistant tumors.
Hong IS; Lee HY; Nam JS
Recent Pat Anticancer Drug Discov; 2015; 10(1):2-22. PubMed ID: 25479037
[TBL] [Abstract][Full Text] [Related]
10. Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance.
Mihanfar A; Aghazadeh Attari J; Mohebbi I; Majidinia M; Kaviani M; Yousefi M; Yousefi B
J Cell Physiol; 2019 Apr; 234(4):3238-3253. PubMed ID: 30317560
[TBL] [Abstract][Full Text] [Related]
11. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
12. Ovarian Cancer Stem Cells: Unraveling a Germline Connection.
Parte SC; Smolenkov A; Batra SK; Ratajczak MZ; Kakar SS
Stem Cells Dev; 2017 Dec; 26(24):1781-1803. PubMed ID: 29078734
[TBL] [Abstract][Full Text] [Related]
13. Cancer Stem Cells and their Management in Cancer Therapy.
Shenouda S; Kulkarni K; Abuetabh Y; Sergi C
Recent Pat Anticancer Drug Discov; 2020; 15(3):212-227. PubMed ID: 32660407
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
15. PTTG1: a Unique Regulator of Stem/Cancer Stem Cells in the Ovary and Ovarian Cancer.
Parte S; Virant-Klun I; Patankar M; Batra SK; Straughn A; Kakar SS
Stem Cell Rev Rep; 2019 Dec; 15(6):866-879. PubMed ID: 31482269
[TBL] [Abstract][Full Text] [Related]
16. Tumor dormancy and cancer stem cells: two sides of the same coin?
Kleffel S; Schatton T
Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
[TBL] [Abstract][Full Text] [Related]
17. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
18. Understanding and targeting cancer stem cells: therapeutic implications and challenges.
Chen K; Huang YH; Chen JL
Acta Pharmacol Sin; 2013 Jun; 34(6):732-40. PubMed ID: 23685952
[TBL] [Abstract][Full Text] [Related]
19. Ovarian cancer stem cells: What progress have we made?
Al-Alem LF; Pandya UM; Baker AT; Bellio C; Zarrella BD; Clark J; DiGloria CM; Rueda BR
Int J Biochem Cell Biol; 2019 Feb; 107():92-103. PubMed ID: 30572025
[TBL] [Abstract][Full Text] [Related]
20. Can nanomedicines kill cancer stem cells?
Zhao Y; Alakhova DY; Kabanov AV
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1763-83. PubMed ID: 24120657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
